choya
2021-08-05
gd
Moderna gained over 2% and reached record high
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
4
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":899876927,"tweetId":"899876927","gmtCreate":1628175758169,"gmtModify":1633752898100,"author":{"id":3585264987238241,"idStr":"3585264987238241","authorId":3585264987238241,"authorIdStr":"3585264987238241","name":"choya","avatar":"https://static.tigerbbs.com/bf32f96fd67870273541927f4a6ed9e6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>gd</p></body></html>","htmlText":"<html><head></head><body><p>gd</p></body></html>","text":"gd","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/899876927","repostId":1106584329,"repostType":4,"repost":{"id":"1106584329","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171968,"share":"https://www.laohu8.com/m/news/1106584329?lang=&edition=full","pubTime":"2021-08-05 21:59","market":"us","language":"en","title":"Moderna gained over 2% and reached record high","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584329","media":"Tiger Newspress","summary":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% eff","content":"<p>(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna gained over 2% and reached record high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna gained over 2% and reached record high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose</p>\n<p><img src=\"https://static.tigerbbs.com/cc2622d5607faa3daa3e1cef13fc4bdf\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna says that its COVID-19 vaccine is 93% effective six months after the second dose.</p>\n<p>That's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.</p>\n<p>Moderna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.</p>\n<p>However, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.</p>\n<p>CEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.</p>\n<p>Moderna beat on income and revenue in its Q2 earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106584329","content_text":"(Aug 5) Moderna beat on income and revenue in its Q2 earnings. Moderna's COVID vaccine shows 93% effectiveness six months after second dose\n\nModerna says that its COVID-19 vaccine is 93% effective six months after the second dose.\nThat's just one percentage point lower than the 94% effectiveness reported in its initial clinical trial that led to the vaccine's Emergency Use Authorization.\nModerna said the sustained efficacy is based on a final analysis of the phase 3 COVE study. The company made the announcement during this morning's Q2 2021 earnings call presentation.\nHowever, the company said it expects antibody levels created by the vaccine to eventually wane, making booster shots likely.\nCEO Stephane Bancel also said Moderna will not manufacture more than the 800M to 1B doses already planned this year because of capacity constraints and is not taking additional orders for deliveries this year.\nModerna beat on income and revenue in its Q2 earnings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":221,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/899876927"}
精彩评论